Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Health Medical Pharma Stories

Diabetes, Pre-Diabetes Cases Have Doubled Over Twenty Years
2014-04-16 03:00:23

Johns Hopkins Bloomberg School of Public Health Alarming Increases in Blacks, Hispanics and the Elderly; Obesity Partly to Blame Cases of diabetes and pre-diabetes in the United States have nearly doubled since 1988, suggests new research from the Johns Hopkins Bloomberg School of Public Health, with obesity apparently to blame for the surge. The researchers also found that the burden of the disease has not hit all groups equally, with alarming increases in diabetes in blacks, Hispanics...

2014-04-16 08:38:32

The site will be free to all subscribers and will allow users to converse without it showing up on their home or work computers. The project will be over a 60 day trial period. SCOTTSDALE, Ariz., April 16, 2014 /PRNewswire/ -- Northsight Capital, Inc., (NCAP OTCBB) announced today an informal joint venture arrangement with the owner of TheAnonymousEmail.com to develop and promote, on a trial basis, the use of the anonymous emailing system by persons discussing, debating, or...

2014-04-16 08:38:17

MISSISSAUGA, ON, April 16, 2014 /PRNewswire/ - EKO International Corp.(the "Company") - (EKNL- Pinksheets) announces that the Company is in the process of preparing adequate current information pursuant to the OTC Pink Basic Disclosure Guidelines. The Company further announces the appointment of Joshua Capogna as Director effective October 13(th), 2013 and the resignation of Rocco DiBenedetto as Director and Officer effective January 1(st), 2014. The Company also announces that...

2014-04-16 08:34:38

MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- ForSight VISION5 is pleased to announce it has recently closed its Series C round of funding and has also completed enrollment in its Phase 2 Clinical Study for the Helios(TM) ocular insert, its lead product candidate. ForSight VISION5 is developing non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5 has completed...

2014-04-16 08:34:35

NSI-566 to be Tested in Patients with Chronic Spinal Cord Injury ROCKVILLE, Md., April 16, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has approved the Phase I safety trial to treat chronic spinal cord injury (cSCI) with its NSI-566 stem cells. The NSI-566/cSCI Phase I trial will enroll patients with thoracic spinal cord injuries (T2-T12) who have an American Spinal...

2014-04-16 08:34:34

BEIJING, April 16, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2013 on April 16, 2014. The Annual Report on Form 20-F is now available on the Company's website under SEC...

2014-04-16 08:34:30

HAYWARD, Calif., April 16, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of authorized generic RENVELA (sevelamer carbonate 800 mg tablets), through Global Pharmaceuticals, Impax's generics division. RENVELA is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. http://photos.prnewswire.com/prnvar/20140402/PH96035LOGO Under the terms of a settlement agreement, Genzyme,...

2014-04-16 08:34:22

Mayo Clinic and Better Team-up to Make the Healthcare Experience Simpler PALO ALTO, Calif. and ROCHESTER, Minn., April 16, 2014 /PRNewswire/ -- Better, a consumer health start-up, and Mayo Clinic today launched a new way for people to navigate the complexity of the healthcare system simply and quickly. Through a mobile device, Better provides tailored Mayo Clinic health information, 24/7 access to the clinic's experienced and highly-skilled nurses, and a Better Personal Health...

2014-04-16 08:34:21

Clinical Results Open Significant Market Opportunity for BioElectronics Corp. FREDERICK, Md., April 16, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced reports on preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. An abstract on the interim analysis of the osteoarthritis (OA) knee pain study has been accepted by...

2014-04-16 08:34:19

ALBANY, N.Y., April 16, 2014 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions taken today are consistent with AMRI's ongoing efforts to consolidate its facility resources to more effectively utilize its discovery and development resource pool and to further reduce its...


Latest Health Medical Pharma Reference Libraries

Obesophobia
2013-12-24 13:50:12

Obesophobia or Pocrescophobia, from the Greek phobia, meaning fear or morbid fear and obeso, meaning fat, is a persistent and abnormal fear of gaining weight, especially in cultures that value being thin. This phobia was listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health. Certain individuals suffering from this phobia originally start with a desire to lose weight which turns into a compulsive desire to avoid all of the things that could result in...

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Phobophobia
2013-12-24 12:34:07

Phobophobia is a phobia defined as the fear of phobias, or the fear of fear, including intense anxiety and unrealistic and persistent fear of the somatic sensations and the feared phobia ensuing. This phobia can also be defined as the fear of developing a phobia. Phobophobia is related to anxiety disorders and panic attacks directly linked to other types of phobias, such as agoraphobia. When a patient has developed this phobia, their condition might be diagnosed and treated as part of anxiety...

Cynophobia
2013-12-24 10:43:28

Cynophobia, from the Greek kyon meaning dog, and phobos, meaning fear, is the abnormal fear of dogs. This phobia is classified as a specific phobia, under the subtype “animal phobias”. According to Dr. Timothy O. Rentz of the Laboratory for the Study of Anxiety Disorders at the University of Texas, animal phobias are among the most common specific phobias and 36 percent who seek out treatment report being afraid of cats or dogs. Although snakes and spider are among the more common in...

Entomophobia
2013-12-24 10:17:24

Entomophobia, known also as insect phobia, is a specific phobia of one or more classes of insects. More specific cases include apiphobia (fear of bees) and myrmecophobia (fear of ants). The symptoms regarding this phobia are much like of the symptoms regarding many other irrational fears. An entomophobic is expected to experience enough anxiety upon viewing or otherwise coming into contact with an insect that he or she experiences full-blown panic attacks. With the extreme and serious...

More Articles (390 articles) »